ArticlePharmaceuticals (Basel, Switzerland)2022

Rituximab in Idiopathic Pulmonary Hemosiderosis in Children: A Novel and Less Toxic Treatment Option.

Suzanne W J Terheggen-Lagro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.